View Clinical Trial (Medical Research Study)

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts - NCT00951795-27514(Clinical Trial 304644)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Chapel Hill
State:  
NC
Zip Code: 27514
Conditions: HIV Infection - AIDS - HIV Infections
Purpose: This is a multi-center study designed to assess the accuracy of Pima™ CD4 Test to enumerate CD4+ T-cells in whole blood over the measurement range expected for the intended population. The Pima CD4 Test consists of the Pima™ CD4 cartridge and Pima™ Analyzer to identify and determine the absolute counts of mature helper (CD3+/CD4+) T-lymphocytes in whole blood.
Study summary: Blood samples will be collected from HIV infected adolescents and adult men and women presenting to a physician's office or outpatient clinic. Capillary whole blood samples will be obtained by fingerstick in duplicate from all Subjects in the study for immediate measurement of CD4+ T-cell count on the Pima CD4 Test by a trained healthcare professional. Venous whole blood samples from all Subjects in the study will also be collected and transported to the clinical laboratory of each study site for concurrent testing on the reference method by a trained laboratory professional. Venous samples from all Subjects in the study will also be measured on the Pima CD4 Test at the study site. Hematocrit will also be measured for all Subjects.
Criteria: Inclusion Criteria: 1. 12 years of age or older 2. Confirmed HIV infection, HIV-1 or HIV-2 according to medical history (this inclusion will be waived for healthy non-HIV infected individuals who may need to be enrolled in order to fill the high end of the CD4+ T-cell measurement range of the Pima CD4 Test. 3. Subject agrees to complete all aspects of the study Exclusion Criteria: 1. Subject has already participated in this study at a previous date 2. Subject is enrolled in a study to evaluate a new drug 3. Patient unable or unwilling to provide informed consent 4. Vulnerable populations as deemed inappropriate for study by site principal investigator.
Study is available at: University of North Carolina
Chapel Hill, NC 27514
United States
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.